Evaluation of the inhibition of carbohydrate hydrolysing enzymes, antioxidant activity and polyphenolic content of extracts of ten African Ficus species (Moraceae) used traditionally to treat diabetes
Some Ficus species have been used in traditional African medicine in the treatment of diabetes. The antidiabetic potential of certain species has been confirmed in vivo but the mechanism of activity remains uncertain. The aim of this study was to determine the activity and to investigate the mechanism of antidiabetic activity of ten selected Ficus species through inhibition of α-amylase and α-glucosidase activity, and the possible relationship between these activities, the total polyphenolic content and the antioxidant activity.
Dried acetone leaf extracts were reconstituted with appropriate solvents and used to determine total polyphenolic content antioxidant activity, α-amylase and α-glucosidase inhibitory activity.
The crude acetone extract of F. lutea had the highest polyphenolic content (56.85 ± 1.82 mg GAE/g of dry material) and the strongest antioxidant activity with a TEAC value of 4.80 ± 0.90. The antioxidant activity of the acetone extracts of the Ficus species may not be ascribed to total polyphenolic content alone. The crude extract at a concentration of 0.5 mg/ml of F. lutea (64.3 ± 3.6%) had the best α-glucosidase (sucrase) inhibitory activity. The EC50 of F. lutea (290 ± 111 μg/ml) was not significantly different from that of F. sycomorus (217 ± 69 μg/ml). The α-amylase inhibitory activity of F. lutea (95.4 ± 1.2%) at a concentration of 1 mg/ml was the highest among the Ficus species screened. The EC50 for F. lutea (9.42 ± 2.01 μ g/ml), though the highest, was not significantly different (p < 0.05) from that of F. craterostoma and F. natalensis. It was apparent that the crude acetone extract of F. lutea is a partially non-competitive inhibitor of α-amylase and α-glucosidase. Based on correlation coefficients polyphenolics may be responsible for α-glucosidase activity but probably not for α-amylase activity.
Antidiabetic activity potential via inhibition of α-amylase and α-glucosidase was discovered in Ficus lutea which has not been previously reported. The acetone extract of the leaves was high in total polyphenolic content and antioxidant activity, and was a potent inhibitor of α-amylase activity. Research is underway to isolate the active compound(s) responsible for the antidiabetic activity and to confirm the in vitro antidiabetic activity and to investigate in vitro toxicity.
KeywordsAfrican Ficus species Ficus lutea Diabetes α-amylase inhibitory activity α- glucosidase inhibitory activity Antioxidant activity Polyphenol content
Diabetes mellitus is an endocrine disease characterised by chronic hyperglycaemia with the disturbance of carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, insulin action or both , and is typically associated with the failure of pancreatic β-cells. There are two major types of diabetes mellitus - type 1 and type 2. In type 1 diabetes, or insulin dependent diabetes mellitus, the body has little or no insulin secretory capacity and depends on exogenous insulin to prevent metabolic disorders and death. In type 2 diabetes, a non-insulin dependent diabetes mellitus, the body retains some endogenous insulin secretory capability; however, their insulin levels are low relative to their blood glucose levels and/or there is a measure of insulin resistance. Type 2 diabetes is the most prevalent form of the disease, accounting for 90-95% of cases [2, 3].
Obesity, a sedentary lifestyle and a diet high in carbohydrate and fats are known risk factors for type 2 diabetes . Globally, 171 million people were diagnosed with the disease in 2000, and it has been predicted that the prevalence will grow to 366 million by 2030 if no intervention action is taken . In sub-Saharan Africa the disease is also considered to be an important emerging disease partly due to changes in diet and lifestyle of the people (a highly refined diet coupled to reduced physical activity). This is brought about by westernization, urbanization and mechanization, i.e. the disease which was once associated with only the affluent has increased in prevalence from 1% to 20% while in South Africa it is 4% to 6% [3, 6, 7].
The prolonged hyperglycaemia that results in diabetic patients has been speculated to induce oxidative stress through the excessive generation of free radicals which may impair endogenous antioxidant defence . The stabilization of blood glucose in diabetic patients is therefore important to prevent these hyperglycaemic complications . The main therapeutic approach used to achieve this objective in the diabetic patient is to stimulate insulin release, increase the number of glucose transporters, inhibit gluconeogenesis or reduce the absorption of glucose . Another therapeutic approach is to decrease the post-prandial hyperglycaemia , which is achieved with the enzyme inhibitors such as acarbose, voglibose and miglitol , which function by retarding the action of the gastrointestinal carbohydrate hydrolysing enzymes α-amylase and α-glucosidase. As a result, these substances delay carbohydrate digestion thereby decreasing the rate of glucose absorption, i.e. they blunt the post-prandial plasma glucose rise . While effective, the gastrointestinal side effects of acarbose, which includes bloating, abdominal discomfort, diarrhoea, and flatulence make them less attractive as therapeutic agents. New anti-diabetic compounds which function by this mechanism but devoid of side effect are therefore desirable [12, 14].
Ficus is a genus of about 800 species of woody trees, shrubs and vines in the family Moraceae. They are found in all tropical habitat types, with about 100 species occurring in Africa and the surrounding islands . Several species of the genus Ficus are used traditionally in a wide variety of ethnomedical remedies all over the world [16, 17]. They have long been used in folk medicine as antidiabetic, anthelmintic, hypotensive, mild laxative, antirheumatic, digestive and anti-dysentery drugs [18, 19]. From previous studies, these plants are known to have chemical constituents such as triterpenes, sterols, polyphenols, flavonoids, coumarins, alkaloids and other metabolites . Polyphenolics are among the naturally occurring antidiabetic agents , which may function via various biological effects, of which one is the inhibition of hydrolysing enzymes . Polyphenolic compounds are also one of the major constituents of medicinal compounds which act as free radical scavengers and antioxidants. Free radicals can react with biological molecules, leading to cell and tissue injuries and pathological events. Therefore the discovery of polyphenolic compounds with a potential to inhibit the activity of digestive enzymes and having excellent antioxidant activity with low adverse effects is important for the treatment of diabetes.
Previous reports on the traditional uses of the selectedFicusspecies *F. religiosais a naturalized exotic from China
F. capreifolia Delile (sandpaper fig)
Infections, vulnerary schistosomiasis
F. cordata Thunb. (Namaqua rock fig)
Treatment of diarrhoea, tuberculosis
F. craterostoma Mildbr. & Burret. (forest fig)
Treatment of stomach ache
F. glumosa Delile (hair rock fig)
Treatment of skin diseases, diabetes,
F. lutea Vahl. (giant-leaves fig)
Treatment of sores, boils, madness, rabies
F. natalensis Hochst. (coastal strangler fig)
Leaf, fruits, bark
Treatment of skin infections, colic, venereal diseases
F. polita Vahl. (heart-leaved fig)
Leaves, fruits, bark, root
Dyspepsia, infectious diseases, abdominal pain, diarrhoea
F. religiosa L. (bo tree or sacred fig)
Treatment of ulcers, bacterial infections, asthma, diabetes
F. sycomorus L. (sycamore fig)
Stem/bark, leaves, root,
Treatment of tumours, inflammation, mental madness, pain, bacterial infections, diabetes
F. thonningii Blume (bark-cloth fig)
Bronchitis, urinary tract infection, epilepsy, diabetes
Ficusspecies demonstrated to have blood glucose lowering potentialin vivo
Materials and chemicals
Dimethyl sulphoxide (DMSO), acetone, methanol and Whatman No. 1 filter paper were purchased from Merck (South Africa). Folin-Ciocalteu reagent, gallic acid, sodium carbonate (Na2CO3), potassium persulphate, ABTS [2, 2–azinobis-(3- ethylbenzothiazoline-6-sulfonic acid)], potato starch, porcine pancreatic α- amylase enzyme (type VI), sodium chloride, sodium phosphate, 3, 5-dinitrosalicylic acid (DNS), sodium potassium tartrate, sodium hydroxide, acarbose, rat intestinal acetone powder, potassium phosphate, sucrose, TRIS (hydroxymethyl) aminomethane, hydrogen chloride (HCl), the glucose oxidase kit (GAGO 20) and Trolox (a synthetic water soluble vitamin E analogue) were sourced from Sigma (South Africa). The absorbance measurements were read using a microtitre plate reader (Versamax, Molecular Devices).
The leaves of ten Ficus species were collected at the Manie van der Schijff Botanical Garden (University of Pretoria), South Africa in February 2009, and voucher specimens were conserved in the HGWJ Schweikerdt Herbarium of the University of Pretoria. The names of plant species and voucher numbers are as follow: Ficus capreifolia Delile - PRU 33124; Ficus cordata Thunb - PRU 35501; Ficus craterostoma Warb. ex Mildbr. & Burret.- PRU 48293; Ficus glumosa Delile - PRU 38554, Ficus lutea Vahl.- PRU 074568; Ficus natalensis Hochst - PRU 078082; Ficus polita Vahl - PRU 35945; Ficus religiosa L. - PRU 115415; Ficus sycomorus L. - PRU 066173; and Ficus thonningii Blume - PRU 57036. The leaves were separated from the stems and dried at room temperature. The dried plant materials were milled to a fine powder in a Macsalab mill (Model 200 LAB, Eriez® Bramley) and stored at room temperature in closed glass bottles in the dark until extracted.
Preparation of plant extracts
The powdered plant material (2 g) was extracted with acetone (20 ml) in polyester centrifuge tubes using a shaker (Labotec model 20.2) at room temperature for 30 min. The extracts were centrifuged and filtered through Whatman No. 1 filter paper. This procedure was repeated three times on the same plant material to ensure that all possible compounds were extracted. The filtered extracts of each species were transferred into pre-weighed glass vials and solvent was left to evaporate at room temperature under a stream of cold air. The percentage yield was expressed on the air-dried mass of the leaves. The dried crude acetone extracts obtained were dissolved in appropriate solvent and used for analyses of total polyphenolics, antioxidant activity and in vitro α-amylase and α-glucosidase inhibition.
Total polyphenolic content
The amount of total polyphenolics was determined using the method described by Djeridane et al. . This method depends on the reduction of Folin-Ciocalteu reagent (a 2 N phosphomolybdic-phosphotungstic reagent) by phenols to a mixture of blue oxides. The commercial reagent was diluted 10-fold with double-distilled water. A standard curve was developed using gallic acid. Different concentrations of gallic acid were prepared in 80% methanol in a 96-well microtitre plate, and their absorbance immediately recorded at 760 nm. The crude acetone extracts were dissolved in 80% methanol to a final concentration of 1 mg/ml. The plant extract (100 μl of the 1 mg/ml) was dissolved in 500 μl (1/10 dilution) of the Folin-Ciocalteu reagent. After the addition of 1000 μl of distilled water the mixture was allowed to stand for 1 min at room temperature, where after 1500 μl of a 20% Na2CO3 solution was added. The final mixture was shaken, followed by an incubation period of 1 h in the dark at room temperature. The absorbance of all samples was measured at 760 nm. All analyses were performed in triplicate and repeated three times. The results are expressed in mg of gallic acid equivalent (GAE) per gram of dry weight of plant material.
Trolox equivalent anti-oxidant capacity (TEAC)
The total antioxidant activity was estimated using the Trolox equivalent capacity (TEAC) test . In this assay, the relative capacity of antioxidant to scavenge the ABTS + [2, 2–azinobis- (3-ethylbenzothiazoline-6-sulfonic acid)] radical compared to the antioxidant potency of Trolox (6–hydroxyl–2,5,7,8-tetramethlchromane-2-carboxylic acid), a synthetic water soluble vitamin E analogue, was measured.
α-Amylase inhibition assay
α- Glucosidase inhibition assay
A commercial rat intestine acetone powder was purchased and used to prepare enzyme solution according to the method of Oki et al.  with slight modifications. In brief, rat intestinal acetone powder (25 mg/ml) was homogenized in ice-cold 50 mM phosphate buffer. After centrifugation at 6 000 × g for 15 min, the clear supernatant obtained was used as the enzyme solution for determining α-glucosidase activity.
The rat intestinal sucrase inhibitory activity was determined using the method of Bhandari et al. , with a slight modification. Sucrose (200 μl of a 56 mM solution) in 0.1 M potassium phosphate buffer (pH 7) was mixed with 100 μl of crude acetone extracts (2.5 mg/ml) in 50% aqueous dimethyl sulphoxide (DMSO) in a test tube. After pre-incubation at 37°C for 5 min, 200 μl of rat intestinal α-glucosidase solution prepared as described above was added. Whereas 100 μl DMSO (50%) was used in place of the plant extract to represent 100% enzyme activity, Acarbose (0.1 mg/ml) was used as the positive control and for the blanks (negative controls) the enzyme solution was replaced with distilled water and the same procedure was carried out as above. Final concentrations in the incubation mixture for plant extracts were 0.5 mg/ml and 0.02 mg/ml for acarbose.
Kinetics of inhibition against α- amylase and α- glucosidase activities
The kinetics of inhibition of the crude acetone extract of F. lutea against α- amylase and α- glucosidase activities were measured by increasing substrate concentrations of starch (0.016% - 0.5%) and sucrose (7 mM – 56 mM) respectively in the absence and presence of extract of F. lutea at concentrations of 25–100 μg/ml for α-amylase inhibitory assay and 62.5 – 250 μg/ml for α- glucosidase inhibitory assay. The type of inhibition was determined by Lineweaver-Burk double reciprocal plot analysis of the data, which was calculated from the result according to Michaelis-Menten kinetics .
Calculation of EC50
A dose response effect was conducted on α- amylase and α-glucosidase for the extracts. The concentrations of extracts used ranged from 16 to 500 μg/ml. The concentration of extract that inhibited 50% of the enzyme activity under assay conditions was defined as the effective concentration (EC50) and this was established using the programme Kinetica 5 (Thermo). The concentration response relationship was plotted and fitted to a Hill’s model. The model was described by the following equation; . The EC50 concentrations attained were used for comparison of the potency of the various crude acetone plant extracts.
All experiments were performed in triplicate and repeated three times to yield nine dose- response curves. Data are presented as the mean ± standard error of mean (S.E.M.). Statistical significances were evaluated by one-way analysis of variance (ANOVA) and student’s t-test, with post hoc analysis using the Bonferroni corrected t-test. P-values less than 0.05 were considered to be significant.
Extraction of plant material
Percentage yield, total polyphenol content and antioxidant activity of crude acetone extracts of leaves of tenFicusspecies
(mg GAE/g dry weight)
4.73 ± 0.26c
0.34 ± 0.05c
8.23 ± 1.00d
0.27 ± 0.03c
9.80 ± 0.93d
0.66 ± 0.06d
19.24 ± 0.79e
1.29 ± 0.30e
56.85 ± 1.82f
4.80 ± 0.90f
4.75 ± 0.92c
0.69 ± 0.08d
8.04 ± 0.52d
0.31 ± 0.06c
5.40 ± 0.35c
0.59 ± 0.18c
12.33 ± 0.26e
1.91 ± 0.19e
4.64 ± 0.48c
0.77 ± 0.06d
Total polyphenol content and antioxidant activity
The total polyphenol content of the crude acetone extracts of the ten Ficus species has highly variable (Table 3), with a range of 4.64 to 56.85 mg GAE/g dry weight of plant. When the total polyphenol content of each extract was compared, the extract of F. lutea (56.85 ± 1.82 mg/g) was found to have a remarkably higher content (p˂0.001) followed in decreasing order by extracts of F. glumosa and F. sycomorus with total polyphenol content of 19.24 ± 0.79 and 12.33 ± 0.26 mg GEA/g dry weight of plant respectively. The extracts with the lowest values in decreasing order were F. natalensis, F. capreifolia and F. thonningii with total phenolic content of 4.75 ± 0.92, 4.73 ± 0.26 and 4.64 ± 0.28 mg GAE/g dry weight of plant respectively.
The antioxidant activities of the extracts, expressed as Trolox equivalent antioxidant capacity (TEAC) are listed in Table 3. The crude acetone extracts of the ten Ficus species had different antioxidant capacities (Table 3). The total antioxidant activity for the ten Ficus species varied widely from 4.80 ± 0.90 to 0.27 ± 0.03 TEAC under the assay conditions. The antioxidant activity of the extract of F. lutea (4.80 ± 0.90 TEAC) was significantly different (p˂0.001) when compared with that of the other extracts, followed by F. sycomorus and F. glumosa in decreasing order with antioxidant activity of 1.91 ± 0.18 and 1.29 ± 0.30 TEAC respectively. The extracts with the lowest TEAC in decreasing order were F. capreifolia, F. polita and F. cordata with 0.34 ± 0.05, 0.31 ± 0.06 and 0.27 ± 0.03 TEAC respectively. The correlation coefficient between total polyphenolic content and TEAC of the crude acetone extracts of the ten Ficus species R2 was 0.50.
α-Amylase inhibitory activity of extracts of Ficus species
The percentage inhibition of α-amylase activity (1 mg/ml) and concentration leading to 50% inhibition (EC50) of crude acetone extracts of the ten selectedFicusspecies
(%) α- amylase inhibitiona
43.8 ± 3.3b
45.9 ± 5.2b
48.3 ± 1.6b
11.41 ± 4.68b
65.1 ± 3.0c
95.4 ± 1.2d
9.42 ± 2.01b
43.7 ± 1.8b
17.85 ± 4.42b
40.2 ± 2.6b
35.3 ± 2.8b
40.0 ± 2.8b
37.6 ± 2.7b
96.7 ± 0.3
0.04 ± 0.03
α-Glucosidase inhibitory activity of extracts of Ficus species
The percentage inhibition of α-glucosidase activity (0.5 mg/ml) and concentration leading to 50% inhibition (EC50) of crude acetone extracts of tenFicusspecies
(%) α-glucosidase inhibitiona
24.3 ± 1.7b
22.0 ± 3.6b
28.2 ± 7.0b
38.7 ± 6.5b
64.3 ± 3.6c
290 ± 111b
23.6 ± 8.1b
29.2 ± 5.8b
17.6 ± 8.0b
35.7 ± 5.4b
217 ± 69b
25.3 ± 5.0b
84.8 ± 1.7
3.4 ± 0.5
The enzyme kinetics of α- amylase and α- glucosidase inhibition by extract of F. lutea
The most challenging goal in the management of type 2 diabetes mellitus is to achieve blood glucose levels as close to normal as physiologically possible . With postprandial hyperglycaemia being the earliest metabolic abnormality detectable, modulation of this rise is an important tool in the management of the diabetic patient [56, 57]. α-Amylases are endoglucanases, which hydrolyse the internal α-1,4 glucosidic linkages in starch, and α- glucosidase (sucrase), one of the glucosidases located in the brush border surface membrane of intestinal cells, is a key enzyme for carbohydrate digestion and absorption. These enzymes have been recognized as therapeutic targets for modulation of postprandial hyperglycaemia. In addition, prolonged hyperglycaemia is an independent risk factor for the development of microvascular and macrovascular complications of diabetes mellitus which is mediated through oxidative stress [55, 58].
In this study the inhibitory effectiveness of the acetone extract of the leaves of ten Ficus species against the α-amylase and α-glucosidase enzymes were evaluated. As a secondary objective, the relationship between total polyphenolic content and antioxidant activity was also studied. For this study, a positive correlation between total polyphenolic content and inhibition of α-amylase and α-glucosidase activity was present with R2 values of 0.65 and 0.74 respectively. This therefore indicates the likelihood of the polyphenols in the acetone extracts being partly responsible for the inhibition of the activity of the enzymes. The latter was not an unexpected finding as the polyphenolic extracts from a number of plants have been previously shown to be effective inhibitors of the intestinal α-glucosidase and α-amylase enzyme systems .
The extracts of ten Ficus species were evaluated for their potential to specifically inhibit activity of porcine pancreatic α-amylase and rat small intestinal α-glucosidase. The ten Ficus species were generally potent inhibitors of activity of the porcine pancreatic α-amylase but weak inhibitors of activity of the rat small intestinal α-glucosidase. Three of the four Ficus species with in vivo blood glucose lowering potential in previous studies (Table 2) were all weak inhibitors of the activity of α-amylase and α-glucosidase in vitro. While the reason for the difference could be due to the different compounds being extracted as a result of different solvents used in these studies, the more likely reason was that the glucose lowering potential of these plants may be due to non-α-amylase or α-glucosidase inhibitory activities, such as the stimulation of glucose uptake, the stimulation of insulin release or the inhibition of gluconeogenesis.
The fourth Ficus species (F. sycomorus) which is used traditionally by the Hausa and Fulani tribes of northern Nigeria to treat diabetes  together with known glucose lowering potential in vivo (Table 2) was a weak inhibitor of α-amylase activity but a potent inhibitor of α-glucosidase (sucrase) activity with an EC50 of 217 ± 69 μg/ml. We therefore believe that the glucose lowering potential demonstrated in vivo by the extract of F. sycomorus may be due to the inhibition of α-glucosidase activity (sucrase). Some authors have shown that the extracts of other Ficus species such as F. racemose, F. benghalensis and F. deltoidea inhibit the activity of sucrase with an EC50 of 367 ± 15.2 μg/ml and 239 ± 14.3 μg/ml respectively for cold and hot water extract of F. racemosa, and 193 ± 21.6 μg/ml and 141 ± 22.1 μg/ml respectively for cold and hot water extract of F. benghalensis. This was in agreement with our results. Furthermore, studies also showed the activity of α-amylase is inhibited with an EC50 of 0.94 ± 0.15% and 0.58 ± 0.15% respectively for the cold and hot water extracts of F. racemosa, and, 4.4 and 125 μg/ml respectively for the cold and hot water extracts of F. benghalensis, this was also in agreement with our results.
Some studies have observed the potency with which polyphenols inhibited the activity of porcine pancreatic α-amylase and rat small intestinal α-glucosidase to be different [59, 64]. Strawberry and raspberry extracts were the most effective inhibitors of α-amylase followed by blueberry and blackcurrant. Although these extracts also inhibited rat intestinal α- glucosidase activity, the order of effectiveness was different than with α-amylase. Blueberry and blackcurrant were the most effective followed by strawberry and raspberry . Rat intestinal α-glucosidase is generally weakly inhibited by many flavonoids, while flavonoids are often potent inhibitors of porcine pancreatic α-amylase . It is possible that the extracts of the Ficus species used in this study demonstrated potent α-amylase inhibitory activity because they contain more of the flavonoid groups with the extract of F. lutea being the most potent.
Polyphenolic compounds may also be indirectly beneficial in disease by chelating metal ions  or activating the expression of antioxidant enzymes  or directly acting as antioxidants . High total phenolic contents may not always translate to a high antioxidant activity. Pulido et al.  reported that antioxidant efficiency of the polyphenols seemed to depend on the position and extent of hydroxylation and conjugation. This was also observed in this study where the correlation between total polyphenolic content and antioxidant activity had an R2 value of 0.5. We found that extracts of F. glumosa, F. sycomorus and F. lutea had good antioxidant activities and high total phenolic contents. Some authors have shown that F. glumosa, F. sycomorus and F. lutea have very good DPPH. scavenging activities with reported IC50 of 79.5 ± 1.77 μg/ml and 11.9 ± 0.3 μg/ml respectively for F. sycomorus and F. lutea, and this is in agreement with our results. Among these three Ficus species, the extract of F. lutea displayed the highest total polyphenolic content and the highest antioxidant activity.
In addition, the qualitative phytochemical analysis conducted (results not included) showed that tannin was one of the prominent phytochemicals contained in the crude acetone extract of F. lutea. Hagerman et al.  reported that the high molecular weight polyphenols (tannins) have the ability to quench free radicals (ABTS+) and their effectiveness depends on the molecular weight, the number of aromatic rings and the nature of the hydroxyl group substitutions. It is also possible that not all polyphenolic compounds possess ABTS + radical scavenging activities . Free radical (ABTS+) scavenging of Ficus species may be due to the presence of high molecular weight polyphenols, such as catechins, pelargonidins and leucopelargonidin derivatives in addition to the flavonoids . A study of the correlation between antioxidant activity and inhibition of α-amylase and α-glucosidase activity by the ten Ficus species had an R2 value of 0.41 and 0.67 respectively indicating that the polyphenolic compounds responsible for antioxidant activity may likely be responsible for the inhibition of α-glucosidase activity but may not be responsible for the inhibition of α-amylase activity. Some authors have demonstrated that compounds with potent antioxidant activity are also strong inhibitors of α-glucosidase activity.
When studying the kinetics of inhibition, the extract of F. lutea showed partial non- competitive inhibition against porcine pancreatic α-amylase and α-glucosidase. A fully non- competitive inhibitor binds the enzyme substrate [ES] complex, not the free enzyme and affects the breakdown of the [ES] to form a product. Likewise, a partial non-competitive inhibitor binds to the enzyme-substrate complex but it is assumed that the inhibitor is released from the enzyme at the same time [ES] is broken down to the product . This type of inhibition does occur where there are multiple inhibitors as will be the case for a crude extract of F. lutea. Another study demonstrated that pure compounds such as D-xylose and (+)- catechin are un-competitive inhibitors of rat intestinal α-glucosidase activity .
The results of this study revealed that the crude acetone extract of F. lutea is high in total polyphenolic content and antioxidant activity, and is a potent inhibitor of α-amylase activity. This in vitro study has demonstrated that polyphenolic compounds present in F. lutea may likely be responsible for the inhibitory activity against the carbohydrate hydrolysing enzymes.
This study investigated the potential antidiabetic activity of ten South African Ficus species, focussing on effects on digestive enzymes, polyphenolic content and antioxidant activity. All acetone extracts of the ten Ficus species had α-amylase and α-glucosidase enzyme inhibitory activity. The crude acetone extract of F. lutea was the most active in all the assays. This is the first report of the antidiabetic potential of F. lutea in potentially lowering blood glucose levels in vitro. The crude acetone extract of F. lutea was more active in vitro than the crude acetone extracts of the three Ficus species that are reported to be used traditionally to treat diabetes. The activity that is responsible for the antidiabetic activity appears to reside in the polar fraction of the extract of F. lutea, so rural people should be able to extract the active compound(s) with water or alcohol. Research is underway to isolate the active compound responsible for the antidiabetic activity, to confirm the in vitro antidiabetic activity, and to investigate toxicity and efficacy in vivo.
The National Research Foundation (NRF) of South Africa provided funding and leaves were collected from the Manie van der Schijff Botanical Garden at the University of Pretoria.
- 1.Anonymous: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. 1999, Geneva: Report of a WHO ConsultationGoogle Scholar
- 13.Rhabasa-Lhoret R, Chiasson JL: α-Glucosidase inhibitors. International Textbook of Diabetes Mellitus, vol. 1. Edited by: Defronzo RA, Ferrannini E, Keen H, Zimmet P. 2004, UK.: John Wiley & Sons Ltd., 901-914. 3Google Scholar
- 18.Watt JM, Breyer-Brandwijk MG: Medicinal and poisonous plants of Southern and Eastern Africa. 1962, London: Livingstone Ltd, 773-780.Google Scholar
- 19.Trivedi P, Hind S, Sharma RC: Preliminary phytochemical and pharmacological studies on Ficus racemosa. J Med Res. 1969, 56: 1070-1074.Google Scholar
- 26.Ghosh R, Sharatchandra KH, Rita S, Thokchom IS: Hypoglycaemic activity of Ficus hispida (bark) in normal and diabetic albino rats. Indian J Pharmacol. 2004, 36: 222-225.Google Scholar
- 29.Musabayane CT, Gondwe M, Kamadyaapa DR, Chuturgoon AA, Ojewole JAO: Effects of Ficus thonningii (Blume) [Moraceae] stem-bark ethanolic extract on blood glucose, cardiovascular and kidney functions of rats, and on kidney cell lines of the proximal (LLC-PK1) and distal tubules (MDBK). Ren Fail. 2007, 29: 389-397.CrossRefPubMedGoogle Scholar
- 31.Mazumder PM, Farswan M, Parcha V: Hypoglycaemic effect of Ficus arnottiana Miq. bark extracts on streptozotocin induced diabetes in rats. Natural Product Radiance. 2009, 8: 478-482.Google Scholar
- 33.Adoum OA, Michael BO, Mohammad IS: Phytochemicals and hypoglycaemic effect of methanol stem-bark extract of Ficus sycomorus Linn (Moraceae) on allozan induced diabetic Wistar albino rats. Afr J Biotechnol. 2012, 11 (17): 4095-4097.Google Scholar
- 34.Adam Z, Khamis S, Ismail A, Hamid M: Ficus deltoidea: a potential alternative medicine for diabetes mellitus. Evidence-Based Complementary and Alternative Medicine. 2012, 10.1155/2012/632763.Google Scholar
- 35.Brink M: Ficus capreifolia Delile. [Internet] Record from Protabase. Edited by: Brink M, Achigan-Dako EG. 2010, Wageningen, Netherlands: PROTA (Plant Resources of Tropical Africa / Resources végétales de l’Afrique tropicale)Google Scholar
- 38.Hutchings A, Scott AH, Lewis G, Cunningham AB: Zulu medicinal plants. An inventory. 1996, Pietermaritzburg: University of Natal Press, 352-Google Scholar
- 40.Chifundera K: Livestock diseases and the traditional medicine in the Bushi area, Kive province, Democratic Republic of Congo. African Study Monographs. 1998, 19: 13-33.Google Scholar
- 41.Cousins D, Huffman MA: Medicinal properties in the diet of gorillas: an ethno- pharmacological evaluation. African Studies Monographs. 2002, 23: 65-89.Google Scholar
- 42.Kuete V, Kamga J, Sandjo LP, Ngameni B, Poumale HMP, Ambassa P, Ngadjui BT: Antimicrobial activities of the methanol extract, fractions and compounds from Ficus polita Vahl. (Moraceae). BMC Complement Altern Med. 2011, 11: 10. 1186/1472-6882-11-6-Google Scholar
- 43.Kirtikar J, Basu B: Ficus religiosa. Indian Medicinal Plants, vol. 10, 2nd edition. Edited by: Blatter E, Caius J, Mhaskar K. 2001, New Delhi: Oriental Enterprises, 3200-3202.Google Scholar
- 44.Simmonds MSJ, Howes MJR: Plants used in the treatment of diabetes. Traditional medicine for modern times - Antidiabetic Plants, 6th volume. Edited by: Soumyanath A. 2006, UK: CRC Press/Taylor and Frances Group, 19-82.Google Scholar
- 47.Etuk EU, Bello SO, Isezuo SA, Mohammed BJ: Ethnobotanical survey of medicinal plants used for the treatment of diabetes mellitus in the north western region of Nigeria. Asian J Exp Biol Sci. 2010, 1: 55-59.Google Scholar
- 55.Tiwari AK, Rao JM: Diabetes mellitus and multiple therapeutic approaches of phytochemicals: Present status and future prospects. Curr Sci. 2002, 83: 30-38.Google Scholar
- 56.Lebovitz HE: α-Glucosidase inhibitors as agents in the treatment of diabetes. Diabetes Review. 1998, 6: 132-145.Google Scholar
- 62.Farsi E, Shafaei A, Hor SY, Khadeer Ahamed MB, Yam MF, Attitalla IH, Asmawi MZ, Ismail Z: Correlation between enzymes inhibitory effects and antioxidant activities of standardised fractions of methanolic extract obtained from Ficus deltoidea leaves. Afr J Biotechnol. 2011, 10 (67): 15184-15194.CrossRefGoogle Scholar
- 63.Ponnusamy S, Ravindran R, Zinjarde S, Bhargava S, Kumar AR: Evaluation of traditional Indian antidiabetic medicinal plants for human pancreatic amylase inhibitory effect in vitro. Evidence-Based Complementary and Alternative Medicine. 2011, 10, 1155/2011515647.Google Scholar
- 73.Dixon M, Webb EC: Enzyme inhibition and activation. Enzymes. 1999, New York: Academic Press Inc, 332-380. Longman Group Ltd. London, 3Google Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/13/94/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.